Citadel Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $706K | Sell |
257,700
-155,100
| -38% | -$491K | ﹤0.01% | 8473 |
|
|
2025
Q4 | $1.53M | Sell |
412,800
-10,100
| -2% | -$32.6K | ﹤0.01% | 6464 |
|
|
2025
Q3 | $1.12M | Buy |
422,900
+48,100
| +13% | +$93K | ﹤0.01% | 7294 |
|
|
2025
Q2 | $369K | Sell |
374,800
-21,600
| -5% | -$21.6K | ﹤0.01% | 9334 |
|
|
2025
Q1 | $571K | Sell |
396,400
-219,900
| -36% | -$405K | ﹤0.01% | 8194 |
|
|
2024
Q4 | $1.36M | Buy |
616,300
+246,900
| +67% | +$576K | ﹤0.01% | 6428 |
|
|
2024
Q3 | $610K | Sell |
369,400
-21,600
| -6% | -$43.6K | ﹤0.01% | 7837 |
|
|
2024
Q2 | $868K | Buy |
391,000
+153,000
| +64% | +$360K | ﹤0.01% | 6878 |
|
|
2024
Q1 | $638K | Buy |
238,000
+98,800
| +71% | +$240K | ﹤0.01% | 7848 |
|
|
2023
Q4 | $416K | Buy |
139,200
+86,200
| +163% | +$112K | ﹤0.01% | 8486 |
|
|
2023
Q3 | $51.9K | Sell |
53,000
-79,900
| -60% | -$116K | ﹤0.01% | 11719 |
|
|
2023
Q2 | $185K | Sell |
132,900
-49,600
| -27% | -$69.3K | ﹤0.01% | 10014 |
|
|
2023
Q1 | $290K | Sell |
182,500
-44,400
| -20% | -$229K | ﹤0.01% | 9446 |
|
|
2022
Q4 | $1.41M | Buy |
226,900
+169,700
| +297% | +$1.21M | ﹤0.01% | 6161 |
|
|
2022
Q3 | $383K | Buy |
57,200
+19,000
| +50% | +$130K | ﹤0.01% | 9042 |
|
|
2022
Q2 | $243K | Buy |
38,200
+15,900
| +71% | +$90.2K | ﹤0.01% | 10279 |
|
|
2022
Q1 | $103K | Sell |
22,300
-51,300
| -70% | -$220K | ﹤0.01% | 12254 |
|
|
2021
Q4 | $368K | Sell |
73,600
-326,300
| -82% | -$2.61M | ﹤0.01% | 10442 |
|
|
2021
Q3 | $4.82M | Buy |
399,900
+17,600
| +5% | +$256K | ﹤0.01% | 4369 |
|
|
2021
Q2 | $8.09M | Buy |
382,300
+294,200
| +334% | +$7.09M | ﹤0.01% | 3454 |
|
|
2021
Q1 | $2.47M | Buy |
88,100
+14,600
| +20% | +$431K | ﹤0.01% | 5906 |
|
|
2020
Q4 | $1.91M | Buy |
73,500
+48,400
| +193% | +$1.45M | ﹤0.01% | 5436 |
|
|
2020
Q3 | $933K | Sell |
25,100
-10,700
| -30% | -$424K | ﹤0.01% | 6157 |
|
|
2020
Q2 | $1.84M | Sell |
35,800
-19,100
| -35% | -$799K | ﹤0.01% | 4734 |
|
|
2020
Q1 | $1.73M | Sell |
54,900
-20,900
| -28% | -$1.1M | ﹤0.01% | 4388 |
|
|
2019
Q4 | $4.52M | Buy |
75,800
+43,800
| +137% | +$1.97M | ﹤0.01% | 3208 |
|
|
2019
Q3 | $1.17M | Buy |
32,000
+7,500
| +31% | +$297K | ﹤0.01% | 5312 |
|
|
2019
Q2 | $1.14M | Sell |
24,500
-34,800
| -59% | -$1.63M | ﹤0.01% | 5483 |
|
|
2019
Q1 | $2.38M | Sell |
59,300
-24,200
| -29% | -$1.09M | ﹤0.01% | 4168 |
|
|
2018
Q4 | $3.84M | Buy |
83,500
+9,300
| +13% | +$448K | ﹤0.01% | 3173 |
|
|
2018
Q3 | $3.29M | Sell |
74,200
-9,100
| -11% | -$418K | ﹤0.01% | 3584 |
|
|
2018
Q2 | $3.27M | Sell |
83,300
-244,900
| -75% | -$12.4M | ﹤0.01% | 3349 |
|
|
2018
Q1 | $23.7M | Buy |
328,200
+45,400
| +16% | +$3.33M | 0.01% | 992 |
|
|
2017
Q4 | $18.6M | Buy |
282,800
+263,500
| +1,365% | +$14.2M | 0.01% | 1199 |
|
|
2017
Q3 | $967K | Buy |
19,300
+800
| +4% | +$38.6K | ﹤0.01% | 4368 |
|
|
2017
Q2 | $856K | Sell |
18,500
-29,200
| -61% | -$1.07M | ﹤0.01% | 4314 |
|
|
2017
Q1 | $1.68M | Buy |
47,700
+37,700
| +377% | +$863K | ﹤0.01% | 3270 |
|
|
2016
Q4 | $125K | Buy |
+10,000
| New | +$119K | ﹤0.01% | 6585 |
|
|
2016
Q2 | – | Sell |
-13,000
| Closed | -$220K | – | 6949 |
|
|
2016
Q1 | $220K | Buy |
13,000
+8,100
| +165% | +$130K | ﹤0.01% | 5520 |
|
|
2015
Q4 | $109K | Sell |
4,900
-13,700
| -74% | -$346K | ﹤0.01% | 6586 |
|
|
2015
Q3 | $439K | Sell |
18,600
-8,400
| -31% | -$527K | ﹤0.01% | 4985 |
|
|
2015
Q2 | $2.21M | Sell |
27,000
-32,000
| -54% | -$3.13M | ﹤0.01% | 2957 |
|
|
2015
Q1 | $5.46M | Buy |
+59,000
| New | +$3.81M | 0.01% | 1954 |
|
Other funds holding ESPR
WA
TSC
O
VCM